Every industry will be impacted by the rise of artificial intelligence, and that certainly will include health care in a big way.
became the latest startup to raise a significant amount of money to help with how we care for ourselves using AI.
The San Mateo, California-based company, whose platform uses AI to help diagnose neurovascular, cardiac and vascular diseases, closed a $75 million Series C funding led by , a subsidiary of .
Search less. Close more.
Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.
RapidAI���s Rapid NCCT Stroke platform gives hospitals imaging and decision support to address possible strokes ��� . The company also has developed modules for cerebral aneurysm management and the identification and notification of a suspected central pulmonary embolism. It hopes to eventually also address other diseases.
���Hospitals are increasingly looking for RapidAI solutions to solve their critical needs, including helping care teams work more efficiently and support clinical decision making for better patient outcomes,��� CEO said in a .
Founded in 2011, the company has now raised $100 million, .
AI in health care
RapidAI is not the only AI-enhanced, health-related startup to see fresh funding from investors hoping to eventually cash in on the intersection of two big sectors: AI and health care.
Seattle-based announced a $43 million Series B, also on Thursday. The startup has developed an AI-driven surgical navigation platform that generates a real-time 3D visualization of the surgery.
Earlier this month, London-based closed a $60 million Series B. The company has created an AI-enhanced platform to help accelerate drug discovery.
With artificial intelligence investment hitting a fever pitch, expect more deals in the health care space when it involves AI-enriched platforms and insights.
Further reading:
Illustration:
Stay up to date with recent funding rounds, acquisitions, and more with the 蹤獲弝け Daily.


67.1K Followers